Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Chromosomal karyotype in chorionic villi of recurrent spontaneous abortion patients.

Du Y, Chen L, Lin J, Zhu J, Zhang N, Qiu X, Li D, Wang L.

Biosci Trends. 2018;12(1):32-39. doi: 10.5582/bst.2017.01296.

2.

Congenital Heart Surgery on In-Hospital Mortality in Trisomy 13 and 18.

Kosiv KA, Gossett JM, Bai S, Collins RT 2nd.

Pediatrics. 2017 Nov;140(5). pii: e20170772. doi: 10.1542/peds.2017-0772. Epub 2017 Oct 18.

3.

Trisomy 13 and 18: Cardiac Surgery Makes Sense if It Is Part of a Comprehensive Care Strategy.

Jenkins KJ, Roberts AE.

Pediatrics. 2017 Nov;140(5). pii: e20172809. doi: 10.1542/peds.2017-2809. No abstract available.

4.

Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.

Petersen AK, Cheung SW, Smith JL, Bi W, Ward PA, Peacock S, Braxton A, Van Den Veyver IB, Breman AM.

Am J Obstet Gynecol. 2017 Dec;217(6):691.e1-691.e6. doi: 10.1016/j.ajog.2017.10.005. Epub 2017 Oct 13.

5.

Transformation of MDS/MPN-RS-T to AML: Trisomy 13, resistant thrombocytosis and transient disease control with oral busulfan therapy.

Barrett A, Catherwood M, Thornton P, Murphy P, Quinn J.

Am J Hematol. 2018 Jan;93(1):E16-E17. doi: 10.1002/ajh.24934. Epub 2017 Nov 3. No abstract available.

PMID:
28984013
6.

Non-invasive prenatal testing (NIPT): Europe's first multicenter post-market clinical follow-up study validating the quality in clinical routine.

Flöck A, Tu NC, Rüland A, Holzgreve W, Gembruch U, Geipel A.

Arch Gynecol Obstet. 2017 Nov;296(5):923-928. doi: 10.1007/s00404-017-4517-3. Epub 2017 Sep 8.

PMID:
28887622
7.
8.

Performance of non-invasive prenatal screening for fetal aneuploidy in twin pregnancies: a meta-analysis.

Liao H, Liu S, Wang H.

Prenat Diagn. 2017 Sep;37(9):874-882. doi: 10.1002/pd.5118. Epub 2017 Aug 14. Review.

PMID:
28728213
9.

Rapid prenatal diagnosis of aneuploidy for chromosomes 21, 18, 13, X, and Y using segmental duplication quantitative fluorescent PCR (SD-QF-PCR).

Sun L, Fan Z, Long J, Weng X, Tang W, Pang W.

Gene. 2017 Sep 5;627:72-78. doi: 10.1016/j.gene.2017.06.014. Epub 2017 Jun 9.

PMID:
28603073
10.

The first trimester combined test for aneuploidies - a single center experience.

Veduta A, Vayna AM, Duta S, Panaitescu A, Popescu F, Bari M, Peltecu G, Nedelea F.

J Matern Fetal Neonatal Med. 2018 Aug;31(16):2091-2096. doi: 10.1080/14767058.2017.1336220. Epub 2017 Jun 14.

PMID:
28553771
11.

A tumor profile in Patau syndrome (trisomy 13).

Satgé D, Nishi M, Sirvent N, Vekemans M, Chenard MP, Barnes A.

Am J Med Genet A. 2017 Aug;173(8):2088-2096. doi: 10.1002/ajmg.a.38294. Epub 2017 May 25. Review.

PMID:
28544599
12.

Long-Term Outcomes of Children With Trisomy 13 and 18 After Congenital Heart Disease Interventions.

Peterson JK, Kochilas LK, Catton KG, Moller JH, Setty SP.

Ann Thorac Surg. 2017 Jun;103(6):1941-1949. doi: 10.1016/j.athoracsur.2017.02.068. Epub 2017 Apr 26.

13.

Novel case of paternal paracentric inversion causing partial trisomy 13 and review of the literature.

Douglas C, Smith SA, Rohena L.

Am J Med Genet A. 2017 Jun;173(6):1673-1680. doi: 10.1002/ajmg.a.38192. Epub 2017 Apr 10.

PMID:
28394407
14.

Revised estimates of the risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18.

Cavadino A, Morris JK.

Am J Med Genet A. 2017 Apr;173(4):953-958. doi: 10.1002/ajmg.a.38123.

PMID:
28328132
15.

The outcomes of 31 cases of trisomy 13 diagnosed in utero with various management options.

Takahashi K, Sasaki A, Wada S, Wada Y, Tsukamoto K, Kosaki R, Ito Y, Sago H.

Am J Med Genet A. 2017 Apr;173(4):966-971. doi: 10.1002/ajmg.a.38132. Epub 2017 Mar 7.

PMID:
28266126
16.

Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS).

Strom CM, Anderson B, Tsao D, Zhang K, Liu Y, Livingston K, Elzinga C, Evans M, Nguyen Q, Wolfson D, Rowland C, Kolacki P, Maxwell M, Wang JC, Rabin D, Catanese J, Owen R, Braastad C, Sun W.

PLoS One. 2017 Mar 1;12(3):e0167130. doi: 10.1371/journal.pone.0167130. eCollection 2017.

17.

Moving toward a shared process: The impact of parent experiences on perinatal palliative care.

Hasegawa SL, Fry JT.

Semin Perinatol. 2017 Mar;41(2):95-100. doi: 10.1053/j.semperi.2016.11.002. Epub 2017 Feb 24.

PMID:
28238454
18.

Using Patient-Centered Care After a Prenatal Diagnosis of Trisomy 18 or Trisomy 13: A Review.

Haug S, Goldstein M, Cummins D, Fayard E, Merritt TA.

JAMA Pediatr. 2017 Apr 1;171(4):382-387. doi: 10.1001/jamapediatrics.2016.4798. Review.

PMID:
28192554
19.

Shared Decision Making for Children With Trisomy 13 and 18.

Brosco JP, Feudtner C.

JAMA Pediatr. 2017 Apr 1;171(4):324-325. doi: 10.1001/jamapediatrics.2016.4943. No abstract available.

PMID:
28192544
20.

The IONA® Test: Development of an Automated Cell-Free DNA-Based Screening Test for Fetal Trisomies 13, 18, and 21 That Employs the Ion Proton Semiconductor Sequencing Platform.

Crea F, Forman M, Hulme R, Old RW, Ryan D, Mazey R, Risley MD.

Fetal Diagn Ther. 2017;42(3):218-224. doi: 10.1159/000455025. Epub 2017 Feb 8.

Supplemental Content

Loading ...
Support Center